Cytokinetics stock forecast
WebApr 10, 2024 · Cytokinetics NasdaqGS:CYTK Stock Report. Last Price. US$34.99. Market Cap. US$3.3b. 7D-7.2%. 1Y-14.8%. Updated. 10 Apr, 2024. Data. Company Financials + 14 Analysts. ... Broker Revenue Forecasts For Cytokinetics, Incorporated (NASDAQ:CYTK) Are Surging Higher Jan 09. Cytokinetics: Biotech That Should Be On Your Radar With … Web2 days ago · In 2024, Cytokinetics's revenue was $94.59 million, an increase of 34.30% compared to the previous year's $70.43 million. Losses were -$388.96 million, 80.6% …
Cytokinetics stock forecast
Did you know?
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. WebFind the latest Cytokinetics, Incorporated CYTK analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range …
WebMar 7, 2024 · Cytokinetics, Incorporated's earnings is forecasted to decline at 23.5% and its revenue is expected to decline at 46.6%. Cytokinetics, Incorporated has a predicted … WebClose price at the end of the last trading day (Wednesday, 1st Mar 2024) of the CYTK stock was $43.11. This is 0.577% less than the trading day before Tuesday, 28th Feb 2024. During the day the stock fluctuated 2.40% from a day low at $42.86 to a day high of $43.89.
WebApr 6, 2024 · Cytokinetics last issued its earnings data on March 1st, 2024. The biopharmaceutical company reported ($1.45) EPS for the quarter, missing the consensus estimate of ($1.22) by $0.23. The firm had revenue of $1.96 million for the quarter, compared to analyst estimates of $7.10 million. Its revenue was down 96.5% on a year … WebApr 6, 2024 · The stock price has decreased by -13.64% in the last 52 weeks. The beta is 0.85, so Cytokinetics's price volatility has been lower than the market average. Beta (1Y)
WebAug 8, 2024 · But note: Cytokinetics may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).
WebApr 5, 2024 · According to analysts' consensus price target of $56.21, Cytokinetics has a forecasted upside of 54.4% from its current price of $36.42. Amount of Analyst Coverage … nottinghamshire singlesWebMar 3, 2024 · Shareholders in Cytokinetics, Incorporated (NASDAQ:CYTK) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts.The analysts have sharply ... how to show only name in zoom meetingWebCYTK Stock 12 Months Forecast $58.50 (66.24% Upside) Based on 13 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The … nottinghamshire singles datingWebDane Leone. Truist. Srikripa Devarakonda, Ph.D. UBS. Ashwani Verma. Cytokinetics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cytokinetics, Inc. 's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cytokinetics, Inc ... nottinghamshire skip hireWebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. how to show only mutual friends on facebookWeb18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Cytokinetics (CYTK) ... * Price Target & Stock Forecast ; Full Company Report ... how to show only weekends in excelWeb1 day ago · See the latest Cytokinetics Inc stock price (NASDAQ:CYTK), related news, valuation, dividends and more to help you make your investing decisions. nottinghamshire sign